focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTruspine Technologies Plc Regulatory News (TSP.PL)

Share Price Information for Truspine Technologies Plc (TSP.PL)

Aquis Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.65
Bid: 1.30
Ask: 2.00
Change: 0.00 (0.00%)
Spread: 0.70 (53.846%)
Open: 1.65
High: 1.65
Low: 1.65
Prev. Close: 1.65
TSP.PL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Mar 2024 12:22

RNS Number : 6370H
TruSpine Technologies PLC
20 March 2024
 

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

TruSpine Technologies PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Geoffrey Richard Miller

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

20/03/2024

6. Date on which issuer notified (DD/MM/YYYY):

20/03/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

6.88%

6.88%

9,611,828

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Ordinary Shares

4,811,828

4,800,000

3.44%

3.44%

SUBTOTAL 8. A

9,611,828

6.88%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

London, UK

Date of completion

20/03/2024

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXJMMTTMTBTBFI
Date   Source Headline
10th May 20247:02 amRNSNotice of 2023 AGM
7th May 20247:00 amRNSDirectorate Change
28th Mar 20247:00 amRNSConvertible Loan Note, Debenture and AGM Update
25th Mar 20247:00 amRNSHolding(s) in Company
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
20th Mar 20242:28 pmRNSHolding(s) in Company
20th Mar 202412:22 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSDirector/PDMR Shareholding
15th Mar 20242:49 pmRNSResult of Adjourned AGM
15th Mar 202410:00 amRNSAGM Statement & Loans Update
14th Mar 20247:00 amRNSIssue of Equity, Warrant Surrender, CLN & RPT
28th Feb 202412:30 pmRNSDirector Appointments
22nd Feb 202410:42 amRNSShareholder Requisition Notice
21st Feb 20243:57 pmRNSNotice of Adjourned AGM
19th Feb 20247:00 amRNSFDA Update
14th Feb 20247:00 amRNSConvertible Loan, Loan Update, AGM Update and RPT
5th Jan 20247:00 amRNSLoan, Related Party Transaction and FDA Update
28th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSCompany Update
30th Oct 20237:00 amRNSFurther re: FDA Update
25th Oct 20238:37 amRNSIP Registration
12th Oct 20237:00 amRNSFurther re: FDA Update
3rd Oct 20237:00 amRNSFurther re: FDA Update
29th Sep 20237:00 amRNSFinal Results
18th Sep 20237:00 amRNSProposed Director Appointments & Update
17th Aug 20231:39 pmRNSResult of Aquis Disciplinary Investigation
15th Aug 20237:00 amRNSSubscription
25th Jul 20237:00 amRNSFurther re: FDA Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.